166 related articles for article (PubMed ID: 12037029)
1. The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry.
van der Laak JA; de Bie LM; de Leeuw H; de Wilde PC; Hanselaar AG
J Clin Pathol; 2002 Jun; 55(6):446-51. PubMed ID: 12037029
[TBL] [Abstract][Full Text] [Related]
2. Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women.
Bygdeman M; Swahn ML
Maturitas; 1996 Apr; 23(3):259-63. PubMed ID: 8794418
[TBL] [Abstract][Full Text] [Related]
3. The effect of oxytocin vaginal gel on vaginal atrophy in postmenopausal women: a randomized controlled trial.
Zohrabi I; Abedi P; Ansari S; Maraghi E; Shakiba Maram N; Houshmand G
BMC Womens Health; 2020 May; 20(1):108. PubMed ID: 32429977
[TBL] [Abstract][Full Text] [Related]
4. Comparative study: Replens versus local estrogen in menopausal women.
Nachtigall LE
Fertil Steril; 1994 Jan; 61(1):178-80. PubMed ID: 8293835
[TBL] [Abstract][Full Text] [Related]
5. Effect of Foeniculum vulgare (fennel) vaginal cream on vaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled trial.
Yaralizadeh M; Abedi P; Najar S; Namjoyan F; Saki A
Maturitas; 2016 Feb; 84():75-80. PubMed ID: 26617271
[TBL] [Abstract][Full Text] [Related]
6. Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial.
Lima SM; Bernardo BF; Yamada SS; Reis BF; da Silva GM; Galvão MA
Maturitas; 2014 Jul; 78(3):205-11. PubMed ID: 24856055
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial.
Fernandes T; Costa-Paiva LH; Pedro AO; Baccaro LF; Pinto-Neto AM
Menopause; 2016 Jul; 23(7):792-8. PubMed ID: 27116462
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Oxytocin Vaginal Gel on Sexual Function in Postmenopausal Women: A Randomized Controlled Trial.
Abedi P; Zohrabi I; Ansari S; Maraghi E; Maram NS; Houshmand G
J Sex Marital Ther; 2020; 46(4):377-384. PubMed ID: 32169019
[TBL] [Abstract][Full Text] [Related]
9. Non-hormonal treatment of vulvo-vaginal atrophy-related symptoms in post-menopausal women.
Tersigni C; Di Simone N; Tempestilli E; Cianfrini F; Russo R; Moruzzi MC; Amar ID; Fiorelli A; Scambia G; Villa P
J Obstet Gynaecol; 2015; 35(8):835-8. PubMed ID: 25968636
[TBL] [Abstract][Full Text] [Related]
10. Monurelle Biogel
Nappi RE; Cagnacci A; Becorpi AM; Nappi C; Paoletti AM; Busacca M; Martella S; Bellafronte M; Tredici Z; Di Carlo C; Corda V; Vignali M; Bagolan M; Sardina M
Climacteric; 2017 Oct; 20(5):467-475. PubMed ID: 28657769
[TBL] [Abstract][Full Text] [Related]
11. Effective treatment of vaginal atrophy with isoflavone vaginal gel.
Lima SM; Yamada SS; Reis BF; Postigo S; Galvão da Silva MA; Aoki T
Maturitas; 2013 Mar; 74(3):252-8. PubMed ID: 23312487
[TBL] [Abstract][Full Text] [Related]
12. Oxytocin improves cytological and histological profiles of vaginal atrophy in postmenopausal women.
Al-Saqi SH; Jonasson AF; Naessén T; Uvnäs-Moberg K
Post Reprod Health; 2016 Mar; 22(1):25-33. PubMed ID: 26883689
[TBL] [Abstract][Full Text] [Related]
13. The vaginal epithelium in the postmenopause--cytology, histology and pH as methods of assessment.
Nilsson K; Risberg B; Heimer G
Maturitas; 1995 Jan; 21(1):51-6. PubMed ID: 7731384
[TBL] [Abstract][Full Text] [Related]
14. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
[TBL] [Abstract][Full Text] [Related]
15. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.
Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH
J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980
[TBL] [Abstract][Full Text] [Related]
16. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
[TBL] [Abstract][Full Text] [Related]
17. The effect of vaginally administered genistein in comparison with hyaluronic acid on atrophic epithelium in postmenopause.
Le Donne M; Caruso C; Mancuso A; Costa G; Iemmo R; Pizzimenti G; Cavallari V
Arch Gynecol Obstet; 2011 Jun; 283(6):1319-23. PubMed ID: 20577750
[TBL] [Abstract][Full Text] [Related]
18. Intravaginally applied oxytocin improves post-menopausal vaginal atrophy.
Al-Saqi SH; Uvnäs-Moberg K; Jonasson AF
Post Reprod Health; 2015 Sep; 21(3):88-97. PubMed ID: 25995333
[TBL] [Abstract][Full Text] [Related]
19. Effect of raloxifene on sexual function in postmenopausal women.
Kessel B; Nachtigall L; Plouffe L; Siddhanti S; Rosen A; Parsons A
Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a vaginal moisturizer in baboons with decreasing ovarian function.
Hubbard GB; Carey KD; Levine H; Bachmann GA
Lab Anim Sci; 1997 Feb; 47(1):36-9. PubMed ID: 9051645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
